Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 186 citing Vijan: Estimated benefits of glycemic control in microvascular complications in type 2 diabetes. (0.12 sec) 

Development and progression of nephropathy in type 2 diabetes: the United Kingdom …


AI Adler, RJ Stevens, SE Manley, RW Bilous, … - Kidney international, 2003 - nature.com
The progression of nephropathy from diagnosis of type 2 diabetes has not been
well described from a single population. This study sought to describe the
development and progression through the stages of microalbuminuria, ...
Cited by 384 - Related articles - BL Direct - All 4 versions

Screening for type 2 diabetes.

- diabetesjournals.org [PDF] 
MM Engelgau, KM Narayan, WH Herman - Diabetes Care, 2000 - Am Diabetes Assoc
In 1997, nearly 16 million people in the US had diabetes (1,2). Of this
population, 10.3 million were diag- nosed and 5.4 million were undiagnosed
(1,2). In the future, these numbers are expected to increase substantially ...
Cited by 221 - Related articles - All 9 versions

Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, …

- annals.org
S Vijan, RA Hayward - Annals of internal medicine, 2003 - Am Coll Physicians
Background: Hypertension in patients with type 2 diabetes mellitus is a
prevalent condition that leads to substantial morbidity and mortality. ...
Purpose: To evaluate the goals and optimal agents for treatment of ...
Cited by 186 - Related articles - BL Direct - All 11 versions

The diabetes quality improvement project

- Free from Publisher
BB Fleming, S Greenfield, MM Engelgau, LM … - Diabetes Care, 2001 - Am Diabetes Assoc
As the worldwide diabetes epidemic continues to unfold, some experts have asked
whether the war against it is being lost (1,2,3). In the US, blindness, kidney
failure, amputations, and cardiovascular disease resulting from diabetes ...
Cited by 164 - Related articles - BL Direct - All 6 versions

Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 …

- rushakoff.com [PDF] 
S Vijan, TP Hofer, RA Hayward - Jama, 2000 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better.
Cited by 155 - Related articles - BL Direct - All 5 versions

Systematic review: comparative effectiveness and safety of oral medications for type 2 …


S Bolen, L Feldman, J Vassy, L Wilson, HC … - Annals of Internal Medicine, 2007 - Am Coll Physicians
Purpose: To summarize the English-language literature on the benefits and harms
of oral agents (second-generation sulfonylureas, biguanides, thiazolidinediones,
meglitinides, and α-glucosidase inhibitors) in the treatment of adults ...
Cited by 147 - Related articles - BL Direct - All 12 versions

Diabetes in elderly adults

- washington.edu [PDF] 
GS Meneilly, D Tessier - Journals of Gerontology Series A: Biological and …, 2001 - Geron Soc America
Diabetes is common in the elderly population. By the age of 75, approximately
20% of the population are afflicted with this illness. Diabetes in elderly
adults is metabolically distinct from diabetes in younger patient ...
Cited by 107 - Related articles - BL Direct - All 6 versions

Narrative review: lack of evidence for recommended low-density lipoprotein treatment …


RA Hayward, TP Hofer, S Vijan - Annals of internal medicine, 2006 - Am Coll Physicians
Recent national recommendations have proposed that physicians should titrate
lipid therapy to achieve low-density lipoprotein (LDL) cholesterol levels less
than 1.81 mmol/L (<70 mg/dL) for patients at very high cardiovascular risk ...
Cited by 98 - Related articles - BL Direct - All 6 versions

Archimedes


DM Eddy, L Schlessinger - Diabetes Care, 2003 - Am Diabetes Assoc
RESULTS—The model includes the pertinent organ systems, more than 50
continuously interacting biological variables, and the major symptoms, tests,
treatments, and outcomes. The level of detail corresponds to that found in ...
Cited by 96 - Related articles - BL Direct - All 5 versions

[PDF] Avoiding pitfalls in chronic disease quality measurement: a case for the next generation of …


EA Kerr, SL Krein, S Vijan, TP Hofer, RA … - American Journal of Managed Care, 2001 - ajmc.com
Eve A. Kerr, MD, MPH; Sarah L. Krein, PhD, RN; Sandeep Vijan, MD, MS; Timothy P.
Hofer, MD, MS; and Rodney A. Hayward, MD ... Current Efforts to Measure the
Quality of Healthcare In 1997, the President's Advisory Commission on ...
Cited by 91 - Related articles - View as HTML - BL Direct - All 3 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google